Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Depending on Tumor Characteristics

NCT04209829 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
600
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Assistance Publique - Hôpitaux de Paris